Moleculin Biotech Inc (MBRX)
4.60
+0.30
(+6.98%)
USD |
NASDAQ |
Apr 23, 16:00
4.53
-0.07
(-1.52%)
After-Hours: 20:00
Moleculin Biotech Market Cap: 10.25M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 10.25M |
| April 22, 2024 | 9.578M |
| April 19, 2024 | 10.36M |
| April 18, 2024 | 10.08M |
| April 17, 2024 | 9.534M |
| April 16, 2024 | 9.534M |
| April 15, 2024 | 9.935M |
| April 12, 2024 | 10.31M |
| April 11, 2024 | 10.63M |
| April 10, 2024 | 11.58M |
| April 09, 2024 | 11.65M |
| April 08, 2024 | 11.25M |
| April 05, 2024 | 11.58M |
| April 04, 2024 | 11.81M |
| April 03, 2024 | 11.69M |
| April 02, 2024 | 12.14M |
| April 01, 2024 | 12.63M |
| March 28, 2024 | 13.16M |
| March 27, 2024 | 12.34M |
| March 26, 2024 | 10.42M |
| March 25, 2024 | 11.69M |
| March 22, 2024 | 12.71M |
| March 21, 2024 | 14.77M |
| March 20, 2024 | 14.05M |
| March 19, 2024 | 17.50M |
| Date | Value |
|---|---|
| March 18, 2024 | 18.38M |
| March 15, 2024 | 16.52M |
| March 14, 2024 | 17.90M |
| March 13, 2024 | 18.72M |
| March 12, 2024 | 18.75M |
| March 11, 2024 | 21.12M |
| March 08, 2024 | 22.52M |
| March 07, 2024 | 22.39M |
| March 06, 2024 | 22.39M |
| March 05, 2024 | 22.52M |
| March 04, 2024 | 22.99M |
| March 01, 2024 | 20.42M |
| February 29, 2024 | 21.02M |
| February 28, 2024 | 20.38M |
| February 27, 2024 | 20.58M |
| February 26, 2024 | 19.68M |
| February 23, 2024 | 18.04M |
| February 22, 2024 | 17.21M |
| February 21, 2024 | 16.75M |
| February 20, 2024 | 16.70M |
| February 16, 2024 | 16.62M |
| February 15, 2024 | 16.71M |
| February 14, 2024 | 17.03M |
| February 13, 2024 | 17.04M |
| February 12, 2024 | 17.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.534M
Minimum
Apr 16 2024
156.31M
Maximum
Feb 10 2021
49.21M
Average
47.10M
Median
Oct 07 2019
Market Cap Benchmarks
| Merck & Co Inc | 321.34B |
| Lixte Biotechnology Holdings Inc | 7.243M |
| Moderna Inc | 41.31B |
| NovaBay Pharmaceuticals Inc | 2.318M |
| Palatin Technologies Inc | 28.24M |
Market Cap Related Metrics
| Price to Book Value | 0.393 |
| Price | 4.60 |
| Earnings Yield | -332.5% |